Clonal evolution in chronic lymphocytic leukemia: Analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance

Genes Chromosomes and Cancer

Volumn 52, Issue 10, 2013, Pages 920-927

  López, Cristina ^a   Delgado, Julio ^a   Costa, Dolors ^a   Villamor, Neus ^a   Navarro, Alba ^a   Cazorla, Maite ^a   Gómez, Cándida ^a   Arias, Amparo ^a   Muñoz, Concha ^a   Cabezas, Sandra ^a   Baumann, Tycho ^a   Rozman, María ^a   Aymerich, Marta ^a   Colomer, Dolors ^a   Pereira, Arturo ^a   Cobo, Francesc ^b   López Guillermo, Armando ^a   Campo, Elías ^a   Carrió, Ana ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL NOSTRA SENYORA DE MERITXELL   (Andorra)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; NOTCH1 MUTATION; NOTCH1 RECEPTOR; PROTEIN KINASE ZAP 70; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CLONAL EVOLUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN HEAVY CHAIN GENE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MULTIVARIATE ANALYSIS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CLONAL EVOLUTION; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; RECEPTOR, NOTCH1;

EID: 84883051303     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22087     Document Type: Article

References (34)

1. Balatti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ, Pekarsky Y, Croce CM. 2011. NOTCH1 mutations in CLL associated with trisomy 12. Blood 119:329-331.
2. Berkova A, Zemanova Z, Trneny M, Schwarz J, Karban J, Cmunt E, Pavlistova L, Brezinova J, Michalova K. 2009. Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization. Neoplasma 56:455-458.
3. Bockstaele F, Verhasselt B, Philippé J. 2009. Prognostic markers in chronic lymphocytic leukemia: A comprehensive review. Blood 23:25-47.
4. Cavazzini F, Rizzotto L, Sofritti O, Daghia G, Cibien F, Martinelli S, Ciccone M, Saccenti E, Dabusti M, Elkareem AA, Bardi A, Tammiso E, Cuneo A, Rigolin GM. 2012. Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients. Leukemia Lymphoma 53:83-88.
5. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. 1996. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87:4990-4997.
6. Chevallier P, Penther D, Avet-Loiseau H, Robillard N, Ifrah N, Mahé B, Hamidou M, Maisonneuve H, Moreau P, Jardel H, Harousseau JL, Bataille R, Garand R. 2002. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol 116:142-150.
7. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. 2005. New Eng J Med 352:804-815.
8. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E. 2003. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. New Eng J Med 348:1764-1775.
9. Del Giudice I, Rossi D, Chiaretti S, Marinelli M, Tavolaro S, Gabrielli S, Laurenti L, Marasca R, Rasi S, Fangazio M, Guarini A, Gaidano G, Foà R. 2012. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica 97:437-441.
10. Dierlamm J, Michaux L, Criel A, Wlodarska I, Van den Berghe H, Hossfeld DK. 1997. Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications. Cancer Genet Cytogenet 94:27-35.
11. Döhner H, Stilgenbauer S, Benner A, Leupolt E., Kröber A, Bullinger L, Döhner K, Bentz M, Lichter P. 2000. Genomic aberrations and survival in chronic lymphocytic leukemia. New Eng J Med 343:1910-1916.
12. Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, Cresta S, Gargiulo E, Forconi F, Guarini A, Arcaini L, Paulli M, Laurenti L, Larocca LM, Marasca R, Gattei V, Oscier D, Bertoni F, Mullighan CG, Foá R, Pasqualucci L, Rabadan R, Dalla-Favera R, Gaidano G. 2011. Analysis of the chronic lymphocytic leukemia coding genome: Role of NOTCH1 mutational activation. J Exp Med 208:1389-13401.
13. Fegan C, Robinson H, Thompson P, Whittaker JA, White D. 1995. Karyotypic evolution in CLL: Identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. Leukemia 9:2003-2008.
14. Finn WG, Kay NE, Kroft SH, Church S, Peterson LC. 1998. Secondary abnormalities of chromosome 6q in B-cell chronic lymphocytic leukemia: A sequential study of karyotypic instability in 51 patients. Am J Hematol 59:223-229.
15. Gunnarsson R, Mansouri L, Isaksson A, Göransson H, Cahill N, Jansson M, Rasmussen M, Lundin J, Norin S, Buhl AM, Smedby KE, Hjalgrim H, Karlsson K, Jurlander J, Geisler C, Juliusson G, Rosenquist R. 2011. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia. Haematologica 96:1161-1169.
16. Hamblin TJ. 2005. Richter's syndrome-the downside of fludarabine? Leukemia Res 29:1103-1104.
17. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. 1999. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848-1854.
18. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK, editors. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2008/; Last accessed on November 2010 SEER data submission, posted to the SEER web site, 2011.
19. Kröber A, Seiler T, Benner A, Bullinger L, Brückle E, Lichter P, Döhner H, Stilgenbauer S. 2002. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100:1410-1416.
20. Leupolt E, Stilgenbauer S, Lichter P, Bentz M, Döhner, H. 1999. Sequential FISH studies in B-CLL reveal clonal evolution with acquisition of deletions involving 6q21, 11q22 and 17p13 (TP53). Blood 94:494.
21. López C, Delgado J, Costa D, Conde L, Ghita G, Villamor N, Navarro A, Cazorla M, Gómez C, Arias A, Muñoz C, Baumann T, Rozman M, Aymerich M, Colomer D, Cobo F, Campo E, López-Guillermo A, Montserrat E, Carrió A. 2012. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations. Genes Chromosomes Cancer 51:881-889.
22. Loscertales J, Arranz E, Sanz MA, Blas C, Gil-Fernández JJ, Burgaleta C, Alegre A. 2010. Clonal evolution in patients with chronic lymphocytic leukemia. Leukemia and Lymphoma 51:1142-1143.
23. Oscier D, Fitchett M, Herbert T, Lambert R. 1991. Karyotypic evolution in B-cell chronic lymphocytic leukaemia. Genes Chromosomes Cancer 3:16-20.
24. Puente XS, Pinyol M, Quesada V, Conde L, Ordóñez GR, Villamor N, Escaramis G, Jares P, Beà S, González-Díaz M, Bassaganyas L, Baumann T, Juan M, López-Guerra M, Colomer D, Tubío JM, López C, Navarro A, Tornador C, Aymerich M, Rozman M, Hernández JM, Puente DA, Freije JM, Velasco G, Gutiérrez-Fernández A, Costa D, Carrió A, Guijarro S, Enjuanes A, Hernández L, Yagüe J, Nicolás P, Romeo-Casabona CM, Himmelbauer H, Castillo E, Dohm JC, de Sanjosé S, Piris MA, de Alava E, San Miguel J, Royo R, Gelpí JL, Torrents D, Orozco M, Pisano DG, Valencia A, Guigó R, Bayés M, Heath S, Gut M, Klatt P, Marshall J, Raine K, Stebbings LA, Futreal PA, Stratton MR, Campbell PJ, Gut I, López-Guillermo A, Estivill X, Montserrat E, López-Otín C, Campo E. 2011. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475:101-105.
25. Quesada V, Conde L, Villamor N, Ordóñez GR, Jares P, Bassaganyas L, Ramsay AJ, Beà S, Pinyol M, Martínez-Trillos A, López-Guerra M, Colomer D, Navarro A, Baumann T, Aymerich M, Rozman M, Delgado J, Giné E, Hernández JM, González-Díaz M, Puente DA, Velasco G, Freije JM, Tubío JM, Royo R, Gelpí JL, Orozco M, Pisano DG, Zamora J, Vázquez M, Valencia A, Himmelbauer H, Bayés M, Heath S, Gut M, Gut I, Estivill X, López-Guillermo A, Puente XS, Campo E, López-Otín C. 2011. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44:47-52.
26. Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F, Marasca R, Laurenti L, Bruscaggin A, Cerri M, Monti S, Cresta S, Famà R, De Paoli L, Bulian P, Gattei V, Guarini A, Deaglio S, Capello D, Rabadan R, Pasqualucci L, Dalla-Favera R, Foà R, Gaidano G. 2012. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 119:521-529.
27. Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadié M, Simonetti A, Lutz JM, Berrino F. HAEMACARE Working Group. 2010. Incidence of hematologic malignancies in Europe by morphologic subtype: Results of the HAEMACARE project. Blood 116:3724-3734; Erratum in: Blood 117:3477.
28. Shaffer LG, Slovak ML, Campbell LJ. 2009. ISCN (2009): An International System for Human Cytogenetic Nomenclature. ISCN Karger, Basel 2009 ISBN 978-3-8055-8985-7.
29. Shanafelt TD, Witzig TE, Fink SR, Jenkins RB, Paternoster SF, Smoley SA, Stockero KJ, Nast DM, Flynn HC, Tschumper RC, Geyer S, Zent CS, Call TG, Jelinek DF, Kay NE, Dewald GW. 2006. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 24:4634-4641.
30. Shedden K, Li Y, Ouillette P, Malek SN. 2012. Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34. Leukemia 26:1108-1110.
31. Stilgenbauer S, Sander S, Bullinger L, Benner A, Leupolt E, Winkler D, Kröber A, Kienle D, Lichter P, Döhner H. 2007. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 92:1242-1245.
32. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editor. 2008. WHO classification of tumours of haematopoietic and lymphoid tisues. IARC: Lyon.
33. Van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, van Krieken JH, Droese J, González D, Bastard C, White HE, Spaargaren M, González M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA. 2003. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257-2317.
34. Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, Werner L, Sivachenko A, DeLuca DS, Zhang L, Zhang W, Vartanov AR, Fernandes SM, Goldstein NR, Folco EG, Cibulskis K, Tesar B, Sievers QL, Shefler E, Gabriel S, Hacohen N, Reed R, Meyerson M, Golub TR, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ. 2011. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. New Eng J Med 365:2497-2250.